1. Home
  2. BMR vs MRKR Comparison

BMR vs MRKR Comparison

Compare BMR & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beamr Imaging Ltd.

BMR

Beamr Imaging Ltd.

N/A

Current Price

$1.09

Market Cap

17.8M

Sector

Technology

ML Signal

N/A

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

N/A

Current Price

$1.00

Market Cap

19.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BMR
MRKR
Founded
2009
1999
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
19.5M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
BMR
MRKR
Price
$1.09
$1.00
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $7.87
AVG Volume (30 Days)
74.7K
★ 173.2K
Earning Date
08-11-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.61
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.19
$19.61
Revenue Next Year
N/A
$375.85
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.06
$0.84
52 Week High
$2.51
$2.46

Technical Indicators

Market Signals
Indicator
BMR
MRKR
Relative Strength Index (RSI) 31.70 40.24
Support Level N/A $0.88
Resistance Level $1.40 $1.32
Average True Range (ATR) 0.10 0.12
MACD -0.06 -0.00
Stochastic Oscillator 1.44 8.67

Price Performance

Historical Comparison
BMR
MRKR

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd provides content-adaptive video compression solutions for human viewing and machine vision. The company is trusted by technology companies such as NVIDIA and Amazon Web Services, and serves media companies including Netflix, Paramount, and JioHotstar. Using Emmy-winning patented technology, its solutions help deliver media content with high quality while reducing storage and delivery costs. Its customers include over-the-top content distributors, video streaming platforms, and Hollywood studios that use its products to store, distribute, and monetize video and images across devices. The company operates in the United States, Israel, and the rest of the world, with the United States generating maximum revenue.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Share on Social Networks: